{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:35:56Z","timestamp":1784090156625,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.yebeh.2023.109091","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T06:40:28Z","timestamp":1674196828000},"page":"109091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Trends in antiseizure medications utilization among women of childbearing age with epilepsy in Poland between 2015 and 2019"],"prefix":"10.1016","volume":"139","author":[{"given":"Katarzyna","family":"W\u00f3jcik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Franciszek Ko\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Dec-\u0106wiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"S\u0142owik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Bosak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2023.109091_b0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1684\/epd.2019.1105","article-title":"Management of epilepsy in pregnancy: A report from the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"21","author":"Tomson","year":"2019","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2023.109091_b0010","unstructured":"https:\/\/stat.gov.pl\/obszary-tematyczne\/ludnosc\/ [accessed 30 September 2022]."},{"key":"10.1016\/j.yebeh.2023.109091_b0015","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/jnnp-2017-317368","article-title":"Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations","volume":"89","author":"Kinney","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2023.109091_b0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yebeh.2018.12.002","article-title":"Trends in valproate use in patients in Germany between 2009 and 2017","volume":"92","author":"Jacob","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109091_b0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2019.07.001","article-title":"Valproate utilisation trends among girls and women from 2013 to 2018","volume":"70","author":"Puteikis","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2023.109091_b0030","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/ene.13610","article-title":"Declining trend in valproate use in Finland among females of childbearing age in 2012\u20132016 \u2013 a nationwide registry-based outpatient study","volume":"25","author":"Virtaa","year":"2018","journal-title":"Eur J Neurol"},{"issue":"11","key":"10.1016\/j.yebeh.2023.109091_b0035","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/pds.4881","article-title":"Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016","volume":"28","author":"Charlton","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.yebeh.2023.109091_b0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.seizure.2020.01.004","article-title":"Valproic acid prescription trends among females of childbearing age in Estonia: A 14-year nationwide prescription database study","volume":"76","author":"Kurvits","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2023.109091_b0045","doi-asserted-by":"crossref","first-page":"e106584","DOI":"10.1016\/j.yebeh.2019.106584","article-title":"Prevalence of valproate prescriptions in women of childbearing age in certain regions of Russia","volume":"101","author":"Kostev","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109091_b0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/epi4.12228","article-title":"Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions","volume":"3","author":"Karlsson Lind","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2023.109091_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107700","article-title":"Real-world prescribing trends of valproate in women with epilepsy in Korea","volume":"115","author":"Han","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109091_b0060","doi-asserted-by":"crossref","first-page":"e117500","DOI":"10.1016\/j.jns.2021.117500","article-title":"Contemporary trends in antiepileptic drug treatment among women of childbearing age with epilepsy in the United States: 2004\u20132015","volume":"427","author":"Ajinkya","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2023.109091_b0065","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamaneurol.2019.0447","article-title":"Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy","volume":"76","author":"Kim","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2023.109091_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2019.06.031","article-title":"Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study","volume":"98","author":"Bosak","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109091_b0075","unstructured":"https:\/\/www.urpl.gov.pl\/pl\/produkty-lecznicze-zawieraj%C4%85ce-walproinian-nowe-ograniczenia-stosowania-wprowadzenie-programu [accessed 28 October 2022]."}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:48:50Z","timestamp":1761504530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505023000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":15,"alternative-id":["S1525505023000094"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109091","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in antiseizure medications utilization among women of childbearing age with epilepsy in Poland between 2015 and 2019","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109091"}}